Joshua Siewert, MD/MBA, is a consultant with a diverse background in medicine, research, and engineering, dedicated to advancing biopharmaceutical solutions for rare diseases. They served as an Engagement Manager at McKinsey & Company from 2021 to 2024, followed by their current role as the Senior Director of Corporate Strategy at Sarepta Therapeutics, where they contribute to precision genetic medicine initiatives. In addition to their work at Sarepta, Joshua is the VP of Portfolio Strategy & Operations at Enveda, coordinating projects including ENV-294. Their education includes a Doctor of Medicine from Yale University School of Medicine and an MBA from Yale School of Management, complemented by degrees in Engineering Physics and Electrical Engineering from the University of Alberta.
Location
Boston, United States
This person is not in any offices